Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3483740

N=C(N)NCCCOc1c(OCCCNC(=N)N)c(F)c2sc(S(=O)(=O)NCP(=O)(O)O)cc2c1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TMPRSS6 Q8IU80 5/20 0.32
F2 P00734 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3483737 1.00 TMPRSS6 (0.32) TMPRSS6F2
SCHEMBL3483910 0.95
SCHEMBL16667526 0.95
SCHEMBL16667525 0.87
SCHEMBL16667438 0.82
SCHEMBL16667139 0.81
SCHEMBL14931290 0.78 TRPV4 (0.36)
SCHEMBL3480026 0.77 CA1 (0.32)
Trifluoroacetic Acid SCHEMBL3950454 0.74 TRPV4 (0.35)
SCHEMBL3484091 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049200-B1 NOVEL INHIBITORS OF BETA-LACTAMASE METHYLGENE INC (CA) 2015-04-29 EP disclosed
US-20100279983-A1 NOVEL INHIBITORS OF BETA-LACTAMASE METHYLGENE INC. 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279983-A1 NOVEL INHIBITORS OF BETA-LACTAMASE MGAM, MGAM2, PGLS TMPRSS6 1200/4885F2 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.